Source:http://linkedlifedata.com/resource/pubmed/id/20854131
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2011-2-14
|
pubmed:abstractText |
Tumor necrosis factor alpha (TNF-?) is thought to be involved in the pathogenic and metabolic events associated with HIV-1 infection. We assessed whether carriage of the TNF-? gene promoter single nucleotide polymorphism (SNP) is associated with lipodystrophy and metabolic derangements in HIV-1-infected patients treated with cART. We also assessed variations in TNF-? receptor plasma levels. The study group comprised 286 HIV-1-infected patients (133 with and 153 without lipodystrophy) and 203 uninfected controls (UC). TNF-? -238G?>?A, -308G?>?A, and -863 C?>?A SNP were assessed using PCR-RFLPs on white cell DNA. Plasma sTNF-? R1 and R2 levels were measured by ELISA. Student's t test, the ?(2) test, Pearson correlations, and the logistic regression test were performed for statistical analysis. The TNF-? -308G?>?A SNP was significantly associated with lipodystrophy in the univariate analysis (p = 0.04). This association, however, was no longer significant in the multivariate analysis. A meta-analysis of the published literature and our own data, which included 284 patients with lipodystrophy and 338 without lipodystrophy, showed that there was no relationship between the TNF-? -238G?>?A and -308G?>?A SNP and lipodystrophy (p?>?0.05 for all comparisons). HIV-1-infected patients had greater sTNF-? R2 plasma levels than UC (p = 0.001) whereas sTNF-? R1 and R2 levels were not significantly different in both the HIV-1-infected cohorts, lipodystrophy vs. nonlipodystrophy (p = NS). In our cohort of white Spaniards the TNF-? -238G?>?A, -308G?>?A, and -863C?>?A SNP were not associated with lipodystrophy in HIV-1-infected patients treated with cART. This finding was replicated in a meta-analysis of the published data, which showed no associations between the TNF-? -238G?>?A and -308G?>?A SNP and lipodystrophy. In HIV-1-infected patients under cART there is a systemic overproduction of sTNF-? R2, which is unrelated to the presence of lipodystrophy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1931-8405
|
pubmed:author |
pubmed-author:AguilarCarmenC,
pubmed-author:AragonésGerardG,
pubmed-author:AsensiVictorV,
pubmed-author:BrochMontserratM,
pubmed-author:DomingoPereP,
pubmed-author:Garcia-PardoGracianoG,
pubmed-author:Hiv Lipodystrophy Study Group,
pubmed-author:López-DuplaMiguelM,
pubmed-author:OlonaMontserratM,
pubmed-author:PardoPedroP,
pubmed-author:PeraireJoaquimJ,
pubmed-author:RichartCristóbalC,
pubmed-author:SirventJoan-JosepJJ,
pubmed-author:VelosoSergiS,
pubmed-author:VendrellJoanJ,
pubmed-author:VidalFrancescF,
pubmed-author:ViladésConsueloC
|
pubmed:issnType |
Electronic
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
143-52
|
pubmed:meshHeading |
pubmed-meshheading:20854131-Adult,
pubmed-meshheading:20854131-Anti-HIV Agents,
pubmed-meshheading:20854131-Case-Control Studies,
pubmed-meshheading:20854131-Drug Therapy, Combination,
pubmed-meshheading:20854131-Female,
pubmed-meshheading:20854131-Genetic Variation,
pubmed-meshheading:20854131-HIV Infections,
pubmed-meshheading:20854131-Humans,
pubmed-meshheading:20854131-Lipodystrophy,
pubmed-meshheading:20854131-Male,
pubmed-meshheading:20854131-Middle Aged,
pubmed-meshheading:20854131-Tumor Necrosis Factor-alpha
|
pubmed:year |
2011
|
pubmed:articleTitle |
No relationship between TNF-? genetic variants and combination antiretroviral therapy-related lipodystrophy syndrome in HIV type 1-infected patients: a case-control study and a meta-analysis.
|
pubmed:affiliation |
Hospital Universitari de Tarragona Joan XXIII, Spain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Meta-Analysis
|